TR201818307A2 - A COMPOSITION CONTAINING DIMETHYL FUMARATE - Google Patents

A COMPOSITION CONTAINING DIMETHYL FUMARATE

Info

Publication number
TR201818307A2
TR201818307A2 TR2018/18307A TR201818307A TR201818307A2 TR 201818307 A2 TR201818307 A2 TR 201818307A2 TR 2018/18307 A TR2018/18307 A TR 2018/18307A TR 201818307 A TR201818307 A TR 201818307A TR 201818307 A2 TR201818307 A2 TR 201818307A2
Authority
TR
Turkey
Prior art keywords
dimethyl fumarate
composition containing
containing dimethyl
pharmaceutically acceptable
pharmaceutical composition
Prior art date
Application number
TR2018/18307A
Other languages
Turkish (tr)
Inventor
Güner Di̇cle
Mollaoğlu Fati̇h
Palantöken Arzu
Türkyilmaz Ali̇
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2018/18307A priority Critical patent/TR201818307A2/en
Priority to PCT/TR2019/050965 priority patent/WO2020112060A1/en
Publication of TR201818307A2 publication Critical patent/TR201818307A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut buluş; dimetil fumarat, en az bir farmasötik olarak kabul edilebilir eksipiyan ve en az iki kaplama katmanına sahip kaplı pelletler içeren bir farmasötik kompozisyon ile ilgilidir.The present invention; relates to a pharmaceutical composition comprising dimethyl fumarate, at least one pharmaceutically acceptable excipient, and coated pellets with at least two coating layers.

TR2018/18307A 2018-11-30 2018-11-30 A COMPOSITION CONTAINING DIMETHYL FUMARATE TR201818307A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2018/18307A TR201818307A2 (en) 2018-11-30 2018-11-30 A COMPOSITION CONTAINING DIMETHYL FUMARATE
PCT/TR2019/050965 WO2020112060A1 (en) 2018-11-30 2019-11-18 A composition comprising dimethyl fumarate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2018/18307A TR201818307A2 (en) 2018-11-30 2018-11-30 A COMPOSITION CONTAINING DIMETHYL FUMARATE

Publications (1)

Publication Number Publication Date
TR201818307A2 true TR201818307A2 (en) 2020-06-22

Family

ID=70854331

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2018/18307A TR201818307A2 (en) 2018-11-30 2018-11-30 A COMPOSITION CONTAINING DIMETHYL FUMARATE

Country Status (2)

Country Link
TR (1) TR201818307A2 (en)
WO (1) WO2020112060A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116251074A (en) * 2023-04-19 2023-06-13 成都百裕制药股份有限公司 Dimethyl fumarate enteric-coated tablet and enteric-coated capsule

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE055779T2 (en) * 2014-11-04 2021-12-28 Adamas Pharmaceuticals Inc Amantadine for improving gait in multiple sclerosis
MA40982A (en) * 2014-11-19 2017-09-26 Biogen Ma Inc PHARMACEUTICAL BALL FORMULATION INCLUDING DIMETHYL FUMARATE

Also Published As

Publication number Publication date
WO2020112060A1 (en) 2020-06-04

Similar Documents

Publication Publication Date Title
DOP2020000102A (en) HELPFUL COMPOUNDS TO INHIBIT CDK7
SV2017005461A (en) BENZAMIDS REPLACED WITH 1,3-TIAZOL-2-ILO
CL2015002472A1 (en) As inhibitors of mutant idh-yl-oxazolidin-2-ones 3-pyrimidin-4.
BR112016028288A2 (en) compound, pharmaceutical composition, methods for treating an individual with a disease or condition and for inhibiting kinase, and use of a compound.
EA201691194A1 (en) RHC STIMULATORS
CL2018000222A1 (en) New combination for use in cancer treatment
BR112018072539A2 (en) increased administration epinephrine compositions
CY1121829T1 (en) GLYCOGONE BASED CATIONIC POLYMERS
EA201690679A1 (en) STABLE PHARMACEUTICAL COMPOSITION CONTAINING AMLODIPIPIN AND VALSARTAN
CY1123871T1 (en) INTEGRIN COMPETITORS
DOP2021000130A (en) HSD17B13 EXPRESSION MODULATORS
CO2017006898A2 (en) Insulin glargine / lixisenatide fixed ratio formulation
MX2023013096A (en) Pharmaceutical use of cyclic peptide compound.
MX2019010950A (en) Phenalene-1-one-containing photosensitizer composition, phenalene-1-one compound and the use thereof.
TR201916829A2 (en) DUAL-LAYER TABLET FORMULATIONS CONTAINING DAPAGLYFLOZIN AND METFORMIN
TR201901516T4 (en) Neuroprotective agents and their uses.
TR201818307A2 (en) A COMPOSITION CONTAINING DIMETHYL FUMARATE
CL2019001618A1 (en) Use of carbamate compounds for prevention, relief or treatment of bipolar disorder.
EA201991265A1 (en) MEDICINAL FORMS WITH DELAYED DELIVERY CONTAINING DIMETHYLFUMARATE
WO2017046228A3 (en) Pharmaceutical association of growth factor receptor agonist and adhesion protein inhibitor for converting a neoplastic cell into a non-neoplastic cell and uses thereof
CO2020015124A2 (en) Human anti-tlr7 antibody
CY1123933T1 (en) LORAZEPAM EXTENDED RELEASE FORMULATIONS
CY1122979T1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF FUNGIASIS
TR201914043A1 (en) EFERVESAN TABLET FORMULATIONS CONTAINING DAPAGLYFLOZIN AND METFORMIN
TR201101809A1 (en) Vildagliptin and glimepiride combinations.